SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-122909
Filing Date
2023-12-01
Accepted
2023-12-01 17:25:44
Documents
14
Period of Report
2023-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330328d1_8k.htm   iXBRL 8-K 40508
2 EXHIBIT 10.1 tm2330328d1_10-1.htm EX-10.1 25955
3 EXHIBIT 10.2 tm2330328d1_10-2.htm EX-10.2 58750
  Complete submission text file 0001104659-23-122909.txt   313948

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jagx-20231025.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20231025_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20231025_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2330328d1_8k_htm.xml XML 3314
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 231460568
SIC: 2834 Pharmaceutical Preparations